4-isopropyl-6-methoxyphenyl glucitol compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9161945
APP PUB NO 20130165645A1
SERIAL NO

13817666

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound, which inhibits SGLT1 (sodium-dependent glucose transporter 1) activity to suppress absorption of glucose or the like, thereby suppressing abnormal glucose tolerance or postprandial hyperglycemia in diabetes, is provided. Specifically, a 4-isopropyl-6-methoxyphenyl glucitol compound represented by the following formula (I), or a pharmaceutically acceptable salt thereof, is provided:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAISHO PHARMACEUTICAL CO LTDTOKYO 170-8633

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chonan, Tomomichi Toshima-ku, JP 6 20
Iwata, Yuki Toshima-ku, JP 10 65
Kakinuma, Hiroyuki Toshima-ku, JP 25 200
Kawabe, Kenichi Toshima-ku, JP 11 43
Kobashi, Yohei Toshima-ku, JP 7 37
Oi, Takahiro Toshima-ku, JP 12 85
Shiozawa, Fumiyasu Toshima-ku, JP 10 73

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 20, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00